LGM
Logos Global Management’s Fulcrum Therapeutics FULC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 57 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 59 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 57 |
|
|
2024
Q1 | – | Sell |
-1,200,000
| Closed | -$8.1M | – | 55 |
|
|
2023
Q4 | $8.1M | Buy |
+1,200,000
| New | +$8.1M | 0.76% | 25 |
|
|
2023
Q1 | – | Sell |
-2,000,000
| Closed | -$14.6M | – | 46 |
|
|
2022
Q4 | $14.6M | Buy |
2,000,000
+50,000
| +3% | +$364K | 1.71% | 22 |
|
|
2022
Q3 | $15.8M | Hold |
1,950,000
| – | – | 1.94% | 19 |
|
|
2022
Q2 | $9.56M | Buy |
1,950,000
+950,000
| +95% | +$4.66M | 1.75% | 17 |
|
|
2022
Q1 | $23.7M | Buy |
1,000,000
+315,000
| +46% | +$7.45M | 3.07% | 17 |
|
|
2021
Q4 | $12.1M | Buy |
+685,000
| New | +$12.1M | 1.25% | 25 |
|
|
2020
Q3 | – | Sell |
-410,000
| Closed | -$7.5M | – | 51 |
|
|
2020
Q2 | $7.5M | Sell |
410,000
-122,520
| -23% | -$2.24M | 1.5% | 23 |
|
|
2020
Q1 | $6.36M | Buy |
532,520
+408,885
| +331% | +$4.88M | 2.42% | 15 |
|
|
2019
Q4 | $2.06M | Buy |
+123,635
| New | +$2.06M | 0.51% | 34 |
|